Top Story

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder
April 27, 2015

Richard J. O’Reilly, MD, chairman of the department of pediatrics at Memorial Sloan Kettering Cancer Center, provides an overview of trials evaluating a large bank of Epstein-Barr virus-specific T cells derived from healthy donors. Results suggest that these T cells can be used for the treatment of patients with Epstein-Barr virus-associated lymphoproliferative disorders that develop after allogeneic hematopoietic stem cell transplant.

“We showed that you can select populations of T cells from these banks and that these can be used to induce durable remissions in over 60% of the patients,” O’Reilly told HemOnc Today.

Medicare’s new payment system gives physicians two options Health Care Legislative and Regulatory Update

Medicare’s new payment system gives physicians two options

April 27, 2015
The Medicare Access and CHIP Reauthorization Act, signed into law on April 16, will make major changes in Medicare payments for physician services. Things start out…
In the Journals

Millions have died worldwide due to lack of access to surgical care, anesthesia

April 27, 2015
Nearly 5 billion people, primarily those in low- to middle-income countries, do not have access to safe surgical and anesthesia care, resulting in 16.9 million…
In the Journals

Researchers identify risk factors for development of pancreatic cancer

April 27, 2015
A team of international researchers developed a profile identifying risk factors for malignancy progression in intraductal papillary mucinous neoplasms of the…
In the Journals

Hodgkin’s lymphoma survivors face high risk for cardiovascular diseases

April 27, 2015
Survivors of Hodgkin’s lymphoma who were treated during adolescence or adulthood faced a high lifetime risk for cardiovascular events, according to study…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

April 26, 2015
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan
morganatic-roan